Screening for ovarian cancer (multiple letters) [1]

Lancet

Volumn 354, Issue 9177, 1999, Pages 509-510

  Manasslev, N ^a   Emery, J ^a   Yaphe, J ^a   Priest, P ^a   Whiteman, D ^a   Chappuis, P O ^a   Narod, S A ^a   Foulkes, W D ^a   Jacobs, I J ^a   Menon, U ^a   MacDonald, N D ^a   Rosenthal, A N ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

CANCER SCREENING; FEMALE; HUMAN; LETTER; OVARY CANCER; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEASIBILITY STUDY; MASS SCREENING; NOTE; OVARY TUMOR; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; SURVIVAL RATE; ADULT; AGED; MIDDLE AGED; MORTALITY; SURVIVAL;

CA-125 ANTIGEN; CROSS-SECTIONAL STUDIES; ENGLAND; FEASIBILITY STUDIES; FEMALE; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY; SURVIVAL RATE; ADULT; AGED; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0033533037     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)75539-2     Document Type: Letter

References (3)

1. IJ Jacobs SJ Skates N McDonald Screening for ovarian cancer: a pilot randomised controlled trial Lancet 353 1999 1207 1210
2. A Eisen BL Weber Primary peritoneal carcinoma can have multifocal origins: implications for prophylactic oophorectomy J Natl Cancer Inst 90 1998 797 799
3. W Burke M Daly J Garber Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRAC1 and BRCA2. Cancer Genetics Studies Consortium JAMA 277 1997 997 1003